challenges of in vivo gene editing for diseases of the hematopoietic system
Published 2 years ago • 281 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
1:27
the challenges of implementing gene therapies for hemophilia in clinical practice
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
1:34
challenges associated with transplantation in patients with mpns
-
2:34
the potential of gene-edited effector cell therapy
-
1:02
the challenge of treating bpdcn in a resource-limited setting
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
3:05
key challenges with implementing gene therapies in clinical practice for hemophilia
-
1:37
long-term follow-up from a phase ii trial of olutasidenib in idh1-mutated aml
-
1:39
challenges associated with the use of novel gvhd therapies in clinical practice
-
9:36
vmp journal club expert answers: gene editing
-
3:07
the challenges associated with crispr gene editing
-
6:31
a meta-analysis assessing the safety of cytoreductive therapies in younger patients with pv
-
1:24
triple-negative myelofibrosis: disease features and outcomes
-
1:45
deciding which patients with mpns are suitable candidates for interferon-based therapy
-
1:04
remaining challenges in improving t-cell therapies for cancer
-
2:01
assessment of visual function: ultra-low & artificial vision
-
1:43
gilteritinib monotherapy vs combination therapy in r/r flt3-mutated aml
-
2:01
in vivo imaging to study cell nonautonomous influences | protocol preview